Neurology · Seizure Disorders
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
Status epilepticus is defined as a single seizure lasting >5 minutes or two or more seizures without a return to baseline consciousness.
The first-line pharmacologic treatment for status epilepticus is an intravenous benzodiazepine, such as lorazepam.
If benzodiazepines fail, the second-line treatment is an intravenous antiepileptic drug (AED), typically fosphenytoin, levetiracetam, or valproic acid.
Refractory status epilepticus that persists despite first- and second-line therapy requires continuous infusion of anesthetics like midazolam, propofol, or pentobarbital.
Nonconvulsive status epilepticus should be suspected in patients with altered mental status who do not return to baseline, requiring urgent EEG for diagnosis.
Hypoglycemia is a critical, reversible cause of status epilepticus, necessitating immediate bedside glucose testing and dextrose administration if indicated.
Excitotoxicity from prolonged seizure activity leads to neuronal cell death and permanent brain injury, making rapid seizure termination the primary clinical goal.
Vignette unlocked
A 45-year-old male is brought to the emergency department by EMS after a generalized tonic-clonic seizure that lasted 12 minutes. Upon arrival, the patient remains unresponsive and is currently experiencing rhythmic jerking of the extremities. His blood glucose is 105 mg/dL. He has no prior history of epilepsy and is not currently taking any medications.
What is the most appropriate next step in management?
Intravenous lorazepam
The patient is in status epilepticus, and the first-line treatment is an intravenous benzodiazepine to rapidly terminate seizure activity as outlined in the first and second bets.
Full handout
High yield triage
Etiology / Epidemiology
Defined as >5 minutes of continuous seizure activity or recurrent seizures without return to baseline. Most common cause is medication non-compliance in known epileptics.
Clinical Manifestations
Characterized by tonic-clonic activity or non-convulsive altered mental status. Continuous seizure activity is the pathognomonic clinical finding.
Diagnosis
Clinical diagnosis; EEG is the gold standard to confirm non-convulsive status. Blood glucose and electrolytes are mandatory initial labs.
Treatment
Benzodiazepines (e.g., Lorazepam) are first-line. Do not delay treatment for imaging.
Prognosis
Mortality increases with duration; neuronal injury occurs after 30-60 minutes of sustained electrical activity.
Full handout
Epidemiology & Etiology
Status epilepticus (SE) is a medical emergency with high morbidity. Primary triggers include subtherapeutic antiepileptic drug levels, alcohol withdrawal, metabolic disturbances, and structural brain lesions like stroke or tumor. In children, febrile illness is a leading precipitant.
Pertinent Anatomy
The limbic system and cerebral cortex are the primary sites of origin. Prolonged activity leads to excitotoxic neuronal death in the hippocampus, thalamus, and cerebellum.
Pathophysiology
Failure of inhibitory mechanisms (GABAergic) and excessive excitatory neurotransmission (glutamate) sustain the seizure. Over time, GABA receptors internalize, rendering the brain increasingly resistant to standard benzodiazepine therapy. This transition to refractory status epilepticus necessitates rapid escalation to second-line agents.
Clinical Manifestations
Patients present with sustained tonic-clonic movements or subtle signs like eye deviation and rhythmic twitching. Respiratory depression and aspiration are immediate life-threats. Non-convulsive SE presents as persistent confusion or coma without overt motor activity, requiring EEG for diagnosis.
Diagnosis
Diagnosis is primarily clinical based on duration >5 minutes. EEG is the gold standard for diagnosing non-convulsive status or monitoring response to therapy. Essential labs include serum glucose, electrolytes, toxicology screen, and antiepileptic drug levels.
Treatment
First-line therapy is Lorazepam (IV). If seizures persist, administer Fosphenytoin or Levetiracetam. Refractory status requires intubation and induction of coma with Propofol or Midazolam infusion. Always check glucose first to rule out hypoglycemia.
Prognosis
Outcome is highly dependent on the underlying etiology and time to seizure cessation. Neuronal necrosis and permanent cognitive deficits are common complications of prolonged episodes. Continuous EEG monitoring is required in the ICU to ensure complete cessation of subclinical activity.
Differential Diagnosis
Pseudoseizures: lack of postictal confusion
Hypoglycemia: corrected by dextrose
Syncope: brief duration, no postictal state
Metabolic encephalopathy: diffuse EEG slowing
Drug toxicity: history of ingestion